DSCSA Implementation is Driving New State Licensing Requirements for Drug Manufacturers

As implementation of the Drug Supply Chain Security Act (DSCSA) continues, pharmaceutical manufacturers are seeing related changes extend into state manufacturer licensing requirements.

Several states are updating licensing rules, applications, and documentation requirements, with increased scrutiny of manufacturers that rely on Contract Manufacturing Organizations (CMOs). For pharmaceutical companies, particularly virtual manufacturers and companies outsourcing production, these changes can create new licensing considerations for both the manufacturer and its CMO relationships.

What is changing?

One important development is the addition of licensing requirements involving manufacturers that use CMOs. In certain states, manufacturers may now need to demonstrate that their CMOs hold appropriate licenses in those states as part of the manufacturer’s own application or renewal process.

Because requirements vary by state and continue to evolve, manufacturers may need to evaluate licensing obligations beyond their own corporate entity and consider how their broader manufacturing structure affects compliance.

Who Is Most Likely to Be Impacted?

The evolving requirements are particularly relevant for:

• Virtual drug manufacturers
• Contract Manufacturing Organizations (CMOs)/Contract Development and Manufacturing Organizations (CDMOs)
• Manufacturers outsourcing some or all production activities
• Companies working with offshore CMOs

Virtual manufacturers may face increased complexity because their ability to obtain a license can be dependent on the licensing status of the organizations performing manufacturing activities on their behalf.

State Manufacturer Licensing: Key Sates to Watch

Manufacturers should closely monitor requirements related to CMO licensing, offshore manufacturing arrangements, and authorized trading partner status.

Key states to watch include:

• Alabama
• Arizona
• Florida
• Kansas
• Minnesota
• Oklahoma
• Oregon
• South Carolina

Requirements vary by state, with some states now requiring licenses for any entity involved in the production of the final drug which ultimately ends up in their state, making it important for manufacturers to evaluate how changes may affect both their own licensing obligations and those of their manufacturing partners.

Why CMO Relationships Matter More

For companies using outsourced manufacturing models, state licensing is increasingly about more than determining whether the manufacturer itself requires a license.

Manufacturers may need to understand:

• Where their CMOs are located and operating
• Whether each CMO maintains required state licenses
• Whether offshore manufacturing creates additional licensing considerations, including but not limited to offshore manufacturing through a different but related entity or parent organization that from a licensing perspective could be viewed as a separate CMO.
• How home-state licensing requirements affect applications in other jurisdictions
• Whether trading partners meet applicable authorization requirements

This can make licensing significantly more complex for companies with multiple manufacturing partners or products produced across several facilities.

What Pharmaceutical Manufacturers Should Consider

As state requirements evolve, manufacturers should maintain visibility into both their own licensing footprint and the licensing status of their manufacturing partners.

Companies utilizing virtual or outsourced manufacturing models should pay particular attention to changes in application requirements and documentation involving CMOs. Identifying and addressing these requirements early can help avoid licensing delays or compliance issues that could disrupt product distribution, interrupt supply chain continuity, or delay products from reaching customers and patients.

Fully Managed State Licensing Support

Managing state licensing requirements across multiple jurisdictions can require ongoing monitoring, application management, renewals and coordination around changing requirements.

Prescription Analytics, Inc. provides fully managed state licensing support services for pharmaceutical manufacturers, helping organizations navigate evolving requirements and maintain their licensing obligations.

Contact us today to learn how we can help support your state licensing needs.